← Eichor
Study identifier: NCT06037096 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Implementation of a Structured Post-pulmonary Embolism Follow-up Model

Condition: Pulmonary Embolism  ·  Sponsor: Aalborg University Hospital

PhaseNA
Planned participants2000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Venous thromboembolism (VTE), clinically presenting as deep vein thrombosis or pulmonary embolism (PE) is the third most frequent cardiovascular disease and is associated with substantial short- and long-term morbidity and mortality and high costs of care. In addition negative physical and mental complications following VTE are common. However in terms of PE, there are no structured follow-up programs in Denmark and there is considerable variation in practice patterns of post-PE management both within and between countries. This project aims to develop, test and implement a structured follow-up care model for patients with PE (The Attend-PE model). This project is a pre-post intervention study and will estimate the effectiveness of implementing the structured follow-up care model on a national level.

This description comes directly from the study's public registry record.

Talk to the study team

Anette A. Højen  ·  +45 29299114  ·  a.wind@rn.dk

Stine F. Lindegaard  ·  +4525545415  ·  s.lindegaard@rn.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Aalborg University HospitalAalborg, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06037096